Literature DB >> 20107529

Growth of microorganisms in total parenteral nutrition solutions without lipid.

Takashi Kuwahara1, Shinya Kaneda, Kazuyuki Shimono, Yoshifumi Inoue.   

Abstract

BACKGROUND: To identify the microorganisms that can grow rapidly in total parenteral nutrition (TPN) solutions, we investigated the growth of the major causes of catheter-related blood stream infection (Staphylococcus aureus, Serratia marcescens, Bacillus cereus, and Candida albicans) in TPN solutions without lipid.
METHODS: Experiment 1: A commercial TPN solution without lipid containing multivitamins (pH5.6) was used. A specific number of each test microorganism was added to each 10 mL of the TPN solution and incubated at room temperature. An aliquot of test solution was sampled and inoculated to SCD agar plates at 0, 24, and 48 hrs after the addition of the microorganisms. The number of microorganisms was counted as colony forming units. Experiment 2: The other 2 commercial TPN solutions without lipid (pH5.5) were supplemented with multivitamins. The pH values of the solutions were adjusted to about 6.0, 6.5, or 7.0 using 0.5 mol/L NaOH. The addition of microorganisms, incubation, and counting were performed in the same manner.
RESULTS: Experiment 1: S. aureus, S. marcescens, and B. cereus did not increase in the TPN solution without lipid containing multivitamins (pH5.6), but C. albicans increased rapidly. Experiment 2: The 3 bacterial species did not increase even at pH6.0, but increased at pH6.5 and increased rapidly at pH7.0 in both TPN solutions. C. albicans increased similarly at any pH.
CONCLUSION: These results suggest that bacterial species cannot grow in TPN solutions without lipid due to the acidity (pH5.6 or lower), but Candida species can grow regardless of the acidity.

Entities:  

Keywords:  CRBSI; TPN solution; growth of microorganism; microbial growth; pH

Mesh:

Substances:

Year:  2010        PMID: 20107529      PMCID: PMC2811814          DOI: 10.7150/ijms.7.43

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN: 1449-1907            Impact factor:   3.738


INTRODUCTION

Catheter-related blood stream infection (CRBSI) is one of the most common complications of intravenous catheters.1-3 Total parenteral nutrition (TPN) solutions are considered to be relatively good growth mediums for microorganisms due to the components.3,4 To reduce or to prevent CRBSI, the growth properties of the microorganisms causing CRBSI in TPN solutions should be understood. Also, the factors which enhance or inhibit microbial growth should be investigated and identified. Because most TPN solutions used in Japan do not contain lipid, we first investigated the growth of the microorganisms in TPN solutions without lipid in this study. All TPN solutions used here contained multivitamins, because Staphylococcus aureus needs multivitamins (or lipid) to increase.5 As the major causes of CRBSI, Staphylococcus aureus, Staphylococcus epidermidis, Serratia marcescens, Escherichia coli, Klebsiella pneumonia, Candida albicans, etc. were shown.1,2,6,7 Furthermore, blood stream infection outbreaks of Bacillus cereus via intravenous line were recently reported in Japan.8 In the present study, therefore, Staphylococcus aureus as a delegate of gram positive cocci, Serratia marcescens as a delegate of gram negative rods, Bacillus cereus as a delegate of gram positive rods, and Candida albicans as a delegate of fungi were examined, and one standard strain and 2 or 3 clinical isolates of each species were employed. To identify which microorganism can grow in TPN solutions, the growth of all strains employed were examined in a commercial TPN solution without lipid in the 1st experiment. To identify which factor is effective to inhibit microbial growth, the growth of the standard strain of each species was examined at different pH values in 2 different osmotic pressure TPN solutions in the 2nd experiment.

MATERIALS AND METHODS

Microorganisms employed

Experiment 1: A standard American Type Culture Collection (ATCC) strain and 2 or 3 clinical isolates were used for each microorganisms; the standard strain ATCC6538 and 3 clinical isolates (N1, N2, N3) of Staphylococcus aureus, the standard strain ATCC13880 and 2 clinical isolates (N4, N5) of Serratia marcescens, the standard strain ATCC11778 and 3 clinical isolates (H1, H2, H3) of Bacillus cereus, and the standard strain ATCC10231 and 3 clinical isolates (N6, N7, N8) of Candida albicans. Experiment 2: The standard strain was used for each microorganism; the ATCC653 of S. aureus, the ATCC13880 of S. marcescens, the ATCC11778 of B. cereus, and the ATCC10231 of C. albicans.

Test solutions

Experiment 1: A commercial TPN solution without lipid containing multivitamins (NP1; NEOPAREN-1, Otsuka Pharmaceutical Factory, Inc., Japan) was used. The composition of NP1 is shown in Table 1, and the pH value is 5.6 and the osmotic pressure ratio to physiological saline (OPR) is approximately 4.
Table 1

The compositions of NP1 AT1V and AT2V

SolutionNP1AT1V AT2V
(volume) (1000 mL) (850 mL) (900 mL)
Amino acids30.0 g25.0 g30.0 g
Glucose120 g79.8 g100.2 g
Fructose-40.2 g49.8 g
Xylitol-19.8 g25.2 g
Na+50 mEq35 mEq35 mEq
K+22 mEq22 mEq27 mEq
Mg2+4 mEq4 mEq5 mEq
Ca2+4 mEq4 mEq5 mEq
Cl-50 mEq35 mEq35 mEq
SO42-4 mEq4 mEq5 mEq
Acetate-36 mEq44 mEq54 mEq
Gluconate--4 mEq5 mEq
Citrate3-4 mEq10 mEq11 mEq
P156 mg154 mg186 mg
Zn20 μmol8 μmol10 μmol
Vitamin B11.53 mg3.1 mg3.1 mg
Vitamin B21.8 mg3.6 mg3.6 mg
Vitamin B62.02 mg4.0 mg4.0 mg
Vitamin B120.0025 mg0.005 mg0.005 mg
Vitamin C50 mg100 mg100 mg
Folic acid0.2 mg0.4 mg0.4 mg
Nicotinamide20 mg40 mg40 mg
Biotin0.03 mg0.06 mg0.06 mg
Panthenol7 mg14 mg14 mg
Vitamin A1650 IU3300 IU3300 IU
Vitamin D30.0025 mg0.005 mg0.005 mg
Vitamin E5 mg10 mg10 mg
Vitamin K1 mg2 mg2 mg
pH5.65.55.5
Osmotic pressure ratio to physiological salineApprox. 4Approx. 5Approx. 6
Experiment 2: The other 2 commercial TPN solutions without lipid (AMINOTRIPA-1 and AMINOTRIPA-2, Otsuka Pharmaceutical Factory, Inc.) were supplemented with multivitamins (Otsuka MV Injection, Otsuka Pharmaceutical Factory, Inc.), and were used as the base solutions (AT1V and AT2V). The compositions of AT1V and AT2V are also shown in Table 1. The pH value and OPR of AT1V are 5.5 and approximately 5, and those of AT2V are 5.5 and approximately 6. The other test solutions were prepared by adjusting the pH of AT1V and AT2V to about 6.0, 6.5, or 7.0 using 0.5 mol/L NaOH. The pH values of the prepared solutions were measured with the pH meter (SevenEasy S20, Mettler-Toledo GmbH, Switzerland), and the results are shown in Table 2.
Table 2

pH values of test solutions

Test solutionTarget pHMeasured pH
AT1V-5.48 (original pH)
6.05.99
6.56.44
7.06.87
AT2V-5.54 (original pH)
6.05.95
6.56.42
7.06.82

Addition of microorganism, incubation and sampling

A specific number of each test microorganism was added to each 10 mL of test solutions in sterile plastic tubes, and all tubes were allowed to stand at room temperature (24-27ºC). An aliquot of test solution was sampled at 0, 24, and 48 hours after the addition of microorganisms.

Measurement of viable microorganisms

Each aliquot sampled was inoculated in Soybean Casein Digest (SCD) agar plate in duplicate. When necessary, the aliquot was diluted 10-fold to 107-fold with physiological saline before inoculating. After 24-hour incubation at 37ºC, the number of colony forming units (CFU) of each microorganism was counted for each plate. The mean CFU of duplicate data was calculated for each aliquot, and the number of each microorganism per mL was calculated using the number of CFU per plate, aliquot volume, and diluting ratio. The results are shown as the values of CFU/mL in semi-logarithmic graphs. The data from 1 standard strain and 2 or 3 clinical isolate strains of each species at 24 and 48 hours (Experiment 1) were analyzed using Student's t-test against the initial data (at 0 hour) to confirm the generality of the results for each species.

RESULTS

Experiment 1

All 4 strains of S. aureus did not increase in NP1 for 48 hours, and isolates N2 and N3 seemed to decrease (Figure 1a). There was a significant decrease (p<0.05) in the mean value of the 4 strains at 48 hours after the addition of microorganisms.
Figure 1

Growth of Staphylococcus aureus (a) Serratia marcescens (b), Bacillus cereus (c) and Candida albicans (d) in NP1 (pH5.6, OPR is approximately 4). The data from 3 or 4 strains of each species at 24 and 48 hrs were analyzed using Student's t-test against the initial data (at 0 hr). *, p<0.05 vs 0hr. **, p<0.01 vs 0 hr. OPR, osmotic pressure ratio to physiological saline.

All 3 strains of S. marcescens did not increase or decrease in NP1 for 48 hours (Figure 1b), and there was no significant difference in the mean values of the 3 strains. All 4 strains of B. cereus did not increase in NP1 for 48 hours (Figure 1c), and there was a significant decrease (p<0.01) in the mean value of the 4 strains at 48 hours. On the other hand, all 4 strains of C. albicans increased rapidly, reaching the maximum concentration within 48 hours (Figure 1d). There were significant increases in the mean values of the 4 strains both at 24hours (p<0.05) and at 48 hours (p<0.01).

Experiment 2

In AT1V, the standard strain of S. aureus did not increase for 48 hours at pH6.0 as well as at the original pH5.5, but increased at pH6.5 and increased rapidly at pH7.0 (Figure 2). The standard strains of S. marcescens (Figure 3) and B. cereus (Figure 4) also did not increase for 48 hours at pH5.5 and pH6.0; furthermore, these strains did not increase even at pH6.5 for 24 hours. However, these strains increased at pH7.0 as S. aureus. On the other hand, the standard strain of C. albicans increased rapidly and equally at any pH value, and reached the maximum concentration within 48 hours (Figure 5).
Figure 2

Effect of pH on the growth of Staphylococcus aureus in AT1V (pH55, OPR is approximately 5) and AT2V (pH5.5, OPR is approximately 6). The pH value was adjusted by adding 0.5 mol/L NaOH. OPR, osmotic pressure ratio to physiological saline.

Figure 3

Effect of pH on the growth of Serratia marcescens in AT1V (pH55, OPR is approximately 5) and AT2V (pH5.5, OPR is approximately 6). The pH value was adjusted by adding 0.5 mol/L NaOH. OPR, osmotic pressure ratio to physiological saline.

Figure 4

Effect of pH on the growth of Bacillus cereus in AT1V (pH55, OPR is approximately 5) and AT2V (pH5.5, OPR is approximately 6). The pH value was adjusted by adding 0.5 mol/L NaOH. OPR, osmotic pressure ratio to physiological saline.

Figure 5

Effect of pH on the growth of Candida albicans in AT1V (pH55, OPR is approximately 5) and AT2V (pH5.5, OPR is approximately 6). The pH value was adjusted by adding 0.5 mol/L NaOH. OPR, osmotic pressure ratio to physiological saline.

Also in AT2V, the standard strains of S. aureus (Figure 2), S. marcescens (Figure 3) and B. cereus (Figure 4) did not increase at pH5.5 and pH6.0, but increased at pH6.5 and pH7.0, except that the growing rates were somewhat less than those in AT1V. The standard strain of C. albicans increased rapidly and reached the maximum concentration within 48 hours at any pH values in AT2V, and the growing rates were the same as those in AT1V (Figure 5).

DISCUSSION

To reduce catheter-related blood stream infection (CRBSI), we have to understand the growth properties of the microorganisms causing CRBSI. Therefore, we investigated the growth of the microorganisms that are known as the major causes of CRBSI, Staphylococcus aureus, Serratia marcescens, Bacillus cereus and Candida albicans, in total parenteral nutrition (TPN) solutions without lipid. In a commercial TPN solution without lipid containing multivitamins (NP1; the pH value is 5.6 and the osmotic pressure ratio to physiological saline [OPR] is approximately 4), all of the standard strains and the clinical isolates of S. aureus, S. marcescens, and B. cereus did not increase. On the other hand, all strains of C. albicans increased rapidly in NP1. These results of Experiment 1 suggested that bacterial species such as Staphylococcus, Serratia and Bacillus can not increase in acidic (pH5.6 or lower) TPN solutions. In fact, the standard strains of these 3 bacterial species did not increase in the other TPN solutions (AT1V; the pH value is 5.5 and the OPR is approximately 5. AT2V; the pH value is 5.5 and the OPR is approximately 6). These standard strains of bacterial species did not increase even at pH6.0, but increased at pH6.5 and pH7.0. At pH6.5 and pH7.0, the growth rates of the standard strains of S. aureus, S. marcescens and B. cereus seemed to be suppressed slightly in AT2V (the OPR is approximately 6) compared with AT1V (the OPR is approximately 5). However, the standard strain of C. albicans increased similarly at any pH and both in AT1V and AT2V as well as in NP1. TPN solutions are considered to be relatively good growth mediums for microorganisms due to the components,3,4 whereas a number of investigators have shown that TPN solutions containing hypertonic glucose and amino acids are poor growth media for most nosocomial pathogens, with the exception of Candida and other yeasts.6,9-11 They estimated that the acidic pH and/or the hyperosmolality might suppress the bacterial growth.9,10,12 The results of 3 bacterial species in this study demonstrated that the acidity of the TPN solution is the critical factor suppressing the bacterial growth, but that the hyperosmolality of conventional TPN solutions has a little effect. On the other hand, the results of C. albicans in this study demonstrated that both the acidic pH and the hyperosmolality of TPN solutions hardly have an effect on Candida growth as reported in other studies.6,11,12 These results suggest that bacterial species cannot grow in TPN solutions without lipid due to the acidity (pH5.6 or lower), but Candida species can grow regardless of the acidity.
  10 in total

Review 1.  Guidelines for the management of intravascular catheter-related infections.

Authors:  L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal:  Clin Infect Dis       Date:  2001-04-03       Impact factor: 9.079

2.  Colonization and bacteremia risk factors in parenteral nutrition catheterization.

Authors:  J Llop; M B Badía; D Comas; M Tubau; R Jódar
Journal:  Clin Nutr       Date:  2001-12       Impact factor: 7.324

3.  Microbiol growth in lipid emulsions used in parenteral nutrition.

Authors:  M A Melly; H C Meng; W Schaffner
Journal:  Arch Surg       Date:  1975-12

Review 4.  Techniques to prevent central venous catheter infections: products, research, and recommendations.

Authors:  Jane Banton
Journal:  Nutr Clin Pract       Date:  2006-02       Impact factor: 3.080

5.  Microbial growth patterns in a total parenteral nutrition formulation containing lipid emulsion.

Authors:  M Gilbert; S C Gallagher; M Eads; M F Elmore
Journal:  JPEN J Parenter Enteral Nutr       Date:  1986 Sep-Oct       Impact factor: 4.016

6.  Microbiological risks in parenteral nutrition compounding.

Authors:  M C Allwood
Journal:  Nutrition       Date:  1997-01       Impact factor: 4.008

7.  Growth of microorganisms in total nutrient admixtures.

Authors:  C E Rowe; T T Fukuyama; J T Martinoff
Journal:  Drug Intell Clin Pharm       Date:  1987 Jul-Aug

8.  Management of suspected nosocomial infection: an audit of 19 hospitalized patients with septicemia caused by Bacillus species.

Authors:  S Matsumoto; H Suenaga; K Naito; M Sawazaki; T Hiramatsu; N Agata
Journal:  Jpn J Infect Dis       Date:  2000-10       Impact factor: 1.362

9.  Total nutrient admixtures appear safer than lipid emulsion alone as regards microbial contamination: growth properties of microbial pathogens at room temperature.

Authors:  M E Didier; S Fischer; D G Maki
Journal:  JPEN J Parenter Enteral Nutr       Date:  1998 Sep-Oct       Impact factor: 4.016

10.  Microbial growth comparisons of five commercial parenteral lipid emulsions.

Authors:  K S Crocker; R Noga; D J Filibeck; S H Krey; M Markovic; W P Steffee
Journal:  JPEN J Parenter Enteral Nutr       Date:  1984 Jul-Aug       Impact factor: 4.016

  10 in total
  12 in total

1.  New potential role of serum apolipoprotein E mediated by its binding to clumping factor A during Staphylococcus aureus invasive infections to humans.

Authors:  Walid F Elkhatib; Pamela S Hair; Julius O Nyalwidhe; Kenji M Cunnion
Journal:  J Med Microbiol       Date:  2015-04       Impact factor: 2.472

2.  Microbial growth in neonatal intravenous fat emulsion administered over 12 versus 24 hours.

Authors:  Bethany M Dedonato; Lisa I Bickford; Ryan J Gates
Journal:  J Pediatr Pharmacol Ther       Date:  2013-10

3.  Growth of microorganisms in total parenteral nutrition solutions containing lipid.

Authors:  Takashi Kuwahara; Kazuyuki Shimono; Shinya Kaneda; Takumi Tamura; Masao Ichihara; Yoshifumi Nakashima
Journal:  Int J Med Sci       Date:  2010-05-18       Impact factor: 3.738

4.  Outbreak of Serratia marcescens bloodstream infections in patients receiving parenteral nutrition prepared by a compounding pharmacy.

Authors:  Neil Gupta; Susan N Hocevar; Heather A Moulton-Meissner; Kelly M Stevens; Mary G McIntyre; Bette Jensen; David T Kuhar; Judith A Noble-Wang; Rick G Schnatz; Shawn C Becker; Eric S Kastango; Nadine Shehab; Alexander J Kallen
Journal:  Clin Infect Dis       Date:  2014-04-11       Impact factor: 9.079

5.  Adding Biotin to Parenteral Nutrition Solutions Without Lipid Accelerates the Growth of Candida albicans.

Authors:  Takashi Kuwahara; Shinya Kaneda; Kazuyuki Shimono
Journal:  Int J Med Sci       Date:  2016-09-15       Impact factor: 3.738

6.  Antimicrobial structure activity relationship of five anthraquinones of emodine type isolated from Vismia laurentii.

Authors:  Gislaine Aurelie Kemegne; Pierre Mkounga; Jean Justin Essia Ngang; Sylvain Leroy Sado Kamdem; Augustin Ephrem Nkengfack
Journal:  BMC Microbiol       Date:  2017-02-22       Impact factor: 3.605

7.  Bactericidal and Antiproliferative Effects of Peripheral Parenteral Nutrition Solutions with Sodium Bisulfite on Pathogenic Microorganisms in Catheter Lumens.

Authors:  Hiroshi Ohara; Masanori Watanabe; Masamu Takebayashi; Saori Abe; Tetsuya Matsuzaki; Masataka Hayasaka
Journal:  Int J Med Sci       Date:  2020-07-11       Impact factor: 3.738

Review 8.  Risk of parenteral nutrition in neonates--an overview.

Authors:  Walter Zingg; Maren Tomaske; Maria Martin
Journal:  Nutrients       Date:  2012-10-16       Impact factor: 5.717

9.  Effects of lipid emulsion and multivitamins on the growth of microorganisms in peripheral parenteral nutrition solutions.

Authors:  Takashi Kuwahara; Shinya Kaneda; Kazuyuki Shimono; Yoshifumi Inoue
Journal:  Int J Med Sci       Date:  2013-06-26       Impact factor: 3.738

10.  Water Soluble Vitamins Enhance the Growth of Microorganisms in Peripheral Parenteral Nutrition Solutions.

Authors:  Sachiko Omotani; Katsuji Tani; Katsuhito Nagai; Yasutoshi Hatsuda; Junji Mukai; Michiaki Myotoku
Journal:  Int J Med Sci       Date:  2017-09-19       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.